Publication | Closed Access

Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells

Hematological MalignancyHealth SciencesMacrocyclic Bisbibenzyl DerivativesMedicineMyeloid NeoplasiaPharmacotherapyAnti-cancer AgentP-glycoprotein-mediated Multidrug ResistancePharmacologyRadiation OncologyDrug DiscoveryDrug Resistance